Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.

Abstract:

OBJECTIVE:Blood tests are usually designed to identify significant fibrosis. We evaluated their diagnostic accuracy, and how to increase it, for the clinically important targets of severe fibrosis and cirrhosis. METHODS:The accuracy for severe fibrosis or cirrhosis of four blood tests was evaluated based on Metavir staging in 1056 patients with chronic hepatitis C recruited in five independent hospitals. RESULTS:Using original scores, an original diagnostic target (significant fibrosis) and best diagnostic cutoff, the correct classification rates in severe fibrosis and cirrhosis stages were, respectively: FibroMeter: 90.1, 100%, Fibrotest: 78.2, 95.1%, Hepascore: 73.8, 94.9%, aspartate aminotransferase to platelet ratio index (APRI): 71.4, 88.0% (P<0.003, P=0.004, respectively, between tests). The corresponding area under the receiver operating characteristics were FibroMeter: 0.885, 0.907, Fibrotest: 0.837, 0.882, Hepascore: 0.834, 0.896, APRI: 0.822, 0.841 (P<0.003, respectively). Observed 100% negative predictive values for severe fibrosis and cirrhosis were, respectively, FibroMeter: 15.4, 47.5%, Fibrotest: 3.6, 31.9%, Hepascore: 0.3, 24.6%, APRI: 1.4, 5.3% of patients (P<0.003, respectively, between tests). By calculating a specific test for cirrhosis, including the FibroMeter markers, the correct classification (93.0%) was significantly higher for the cirrhosis diagnosis compared with the original FibroMeter (90.9%, P=0.005). This specific test provided a 100% positive predictive value for cirrhosis diagnosis versus 88% for original FibroMeter. CONCLUSION:Using the most accurate original test, cirrhosis can be excluded in 47.5% of patients and is correctly diagnosed, as significant fibrosis, in 100% of patients. A specific test for cirrhosis provides a significant gain in diagnostic accuracy to 93% and in positive predictive value to 100% compared with the original test.

authors

Boursier J,Bacq Y,Halfon P,Leroy V,de Ledinghen V,de Muret A,Bourlière M,Sturm N,Foucher J,Oberti F,Rousselet MC,Calès P

doi

10.1097/MEG.0b013e32830cebd7

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

28-38

issue

1

eissn

0954-691X

issn

1473-5687

pii

00042737-200901000-00004

journal_volume

21

pub_type

杂志文章,多中心研究,评审
  • Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis.

    abstract:AIM:Many researchers consider portal thrombosis (PT) as a contraindication to transjugular intrahepatic portosystemic shunt (TIPS). The aim of this retrospective study was to compare the feasibility and long-term prognosis of TIPS in cirrhotic patients, with and without, complete PT. PATIENTS AND METHODS:Four hundred ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e328338d995

    authors: Perarnau JM,Baju A,D'alteroche L,Viguier J,Ayoub J

    更新日期:2010-09-01 00:00:00

  • How patients with long-term experience of living with irritable bowel syndrome manage illness in daily life: a qualitative study.

    abstract:OBJECTIVES:Irritable bowel syndrome (IBS) is a chronic, disabling and functional gastrointestinal disorder. Effective treatments are lacking. Self-care and coping with symptoms are considered important but little is known about what patients with IBS actually do to manage their illness. The aim of this study was to exp...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e328365abd3

    authors: Jakobsson Ung E,Ringstrom G,Sjövall H,Simrén M

    更新日期:2013-12-01 00:00:00

  • Epidemiology of cancer from the oral cavity and oropharynx.

    abstract::The classification of sites in tumors of the oral cavity, oropharynx, pharynx, and hypopharynx varies in the literature. More than 90% of these tumors of the mucosal lining are classified as squamous cell carcinoma developed from premalignant lesions such as leukoplakia and erythroleukoplakia. These carcinomas are ass...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,评审

    doi:10.1097/MEG.0b013e3283484795

    authors: Lambert R,Sauvaget C,de Camargo Cancela M,Sankaranarayanan R

    更新日期:2011-08-01 00:00:00

  • Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.

    abstract:OBJECTIVE:There has been a dramatic increase in recent years in the incidence of Barrett's oesophagus and the oesophageal adenocarcinoma associated with it. Alongside surgical treatment for early Barrett's carcinomas, endoscopic treatment procedures such as photodynamic therapy (PDT), which have much lower complication...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200206000-00011

    authors: Pech O,Nagy CD,Gossner L,May A,Ell C

    更新日期:2002-06-01 00:00:00

  • Gastric emptying time in patients with primary hypothyroidism.

    abstract:BACKGROUND AND OBJECTIVES:Symptoms due to slowing of gastrointestinal motility constitute an important problem in most patients with primary hypothyroidism. The purpose of this study was to calculate gastric emptying time in patients with primary hypothyroidism using a radioisotopic method. PATIENTS AND METHODS:Fiftee...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199709000-00014

    authors: Kahraman H,Kaya N,Demirçali A,Bernay I,Tanyeri F

    更新日期:1997-09-01 00:00:00

  • Cholescintigraphy in patients with acute cholecystitis before and after percutaneous gallbladder drainage.

    abstract:OBJECTIVE:To investigate gallbladder function by use of cholescintigraphy in patients with acute cholecystitis before and after percutaneous gallbladder drainage. DESIGN:A cholescintigraphy was performed in 40 patients with acute cholecystitis before and after the performance of percutaneous gallbladder drainage. Duri...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199511000-00013

    authors: Borly L,Stage JG,Grønvall S,Højgaard L

    更新日期:1995-11-01 00:00:00

  • Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response?

    abstract:BACKGROUND AND AIM:There are millions of chronic hepatitis C (CHC) virus-infected patients who have been treated with a combination therapy (interferon and ribavirin) and have achieved a virological response (SVR) worldwide. The aim of this study is to evaluate the risk factors for de-novo diabetes mellitus in CHC pati...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000929

    authors: Mousa N,Abdel-Razik A,Farag R,Shabana W,Elgamal A,El-Wakeel N,Elzehery R,Elkashef W,Eldars W

    更新日期:2017-09-01 00:00:00

  • Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans?

    abstract::Syndecan expression, or the lack thereof by tumor cells, has been associated with poor prognosis in several types of cancer, including colorectal cancer. Syndecan is a heparan sulfate proteoglycan involved in tumor adhesion, invasion, and metastasis. In addition, the expression of the enzyme heparanase by cancer cells...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 评论,杂志文章,评审

    doi:10.1097/MEG.0b013e3282fc2660

    authors: Giordano RJ

    更新日期:2008-08-01 00:00:00

  • Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?

    abstract::Physicians should try to reach an optimal cure rate with initial anti-Helicobacter therapy. Helicobacter pylori infection in patients with peptic ulcer disease (PUD) is more likely to be cured then in patients with 'functional' dyspepsia (FD). Differences in cure rates of 5-15% are usually reported, which is considere...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 评论,杂志文章

    doi:10.1097/00042737-200111000-00002

    authors: de Boer WA,Tytgat GN

    更新日期:2001-11-01 00:00:00

  • Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis.

    abstract:OBJECTIVE:Transjugular intrahepatic portosystemic stent-shunt (TIPSS) is increasingly used to treat complications of portal hypertension, but proven tools for risk assessment of early mortality are lacking. DESIGN:The prospective evaluation of a new 60-day mortality score. PATIENTS AND METHODS:In a tertiary medical c...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200207000-00003

    authors: Brensing KA,Raab P,Textor J,Görich J,Schiedermaier P,Strunk H,Paar D,Schepke M,Sudhop T,Spengler U,Schild H,Sauerbruch T

    更新日期:2002-07-01 00:00:00

  • Palliative chemotherapy in advanced gastrointestinal cancer.

    abstract::In this review, the role of chemotherapy in the palliative treatment of advanced gastrointestinal cancer is discussed. Emphasis is placed on chemotherapy-related problems, current chemo-therapy options, and new developments. ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,评审

    doi:10.1097/00042737-200012040-00004

    authors: van Riel JM,van Groeningen CJ

    更新日期:2000-04-01 00:00:00

  • Contemporary management of perihilar cholangiocarcinoma in a nontransplant hepatopancreatobiliary center.

    abstract:BACKGROUND:Perihilar cholangiocarcinoma (PHCC) is a rare tumor with a poor prognosis. Outcomes may be optimized by centralization. Recent trends suggest further improvement by localization to transplant centers. This study examines outcomes from the management of PHCC in a nontransplant hepatopancreatobiliary center. ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e32835fba3a

    authors: Jegatheeswaran S,Sheen AJ,Siriwardena AK

    更新日期:2013-09-01 00:00:00

  • Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.

    abstract:BACKGROUND:Recently, the serotonin antagonist ondansetron has been reported to have a positive effect on cholestasis-associated pruritus. OBJECTIVES:To study the effect of orally administered ondansetron on pruritus in chronic liver disease in a randomized, placebo-controlled, double-blind, cross-over study. METHODS:...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00042737-199810000-00010

    authors: Müller C,Pongratz S,Pidlich J,Penner E,Kaider A,Schemper M,Raderer M,Scheithauer W,Ferenci P

    更新日期:1998-10-01 00:00:00

  • Use of KAI-1 as a prognostic factor in gastric carcinoma.

    abstract:AIMS:The purpose of this study was to investigate the expression level of KAI-1 in gastric carcinomas and compare with the clinicopathological characteristics. METHODS:KAI-1 expressions were detected with immunohistochemical methods in 257 patients with gastric carcinomas. RESULTS:KAI-1 was highly expressed in normal...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e328323aac9

    authors: Ilhan O,Celik SY,Han U,Onal B

    更新日期:2009-12-01 00:00:00

  • Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

    abstract:OBJECTIVE:Recent studies have suggested that endotoxin-induced cytokines play an important role in nonalcoholic fatty liver disease (NAFLD). Rifaximin is a nonabsorbable antibiotic that might act on Gram-negative bacteria, thereby inhibiting endotoxin proinflammatory cytokine production in patients with NAFLD. Our aim ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000000348

    authors: Gangarapu V,Ince AT,Baysal B,Kayar Y,Kılıç U,Gök Ö,Uysal Ö,Şenturk H

    更新日期:2015-07-01 00:00:00

  • Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure.

    abstract:OBJECTIVE:To evaluate the haemodynamic changes during treatment with high-volume plasmapheresis in patients with chronic liver failure compared to patients with acute liver failure. METHODS:Haemodynamic measurements were performed with a Swan-Ganz catheter and thermodilution technique. High-volume plasmapheresis (mean...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199701000-00014

    authors: Clemmesen JO,Larsen FS,Ejlersen E,Schiødt FV,Ott P,Hansen BA

    更新日期:1997-01-01 00:00:00

  • Report of a collaborative trial to investigate the performance of the R5 enzyme linked immunoassay to determine gliadin in gluten-free food.

    abstract:OBJECTIVE:Analytical methods for measurements of gluten in the low level range of 20-200 ppm of gluten, as required for gluten-free food, have never been endorsed by the Codex Alimentarius. With the aim of investigating standardized and reliable methods for the detection of gliadin in food with detection limits lower t...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,多中心研究

    doi:10.1097/00042737-200510000-00008

    authors: Méndez E,Vela C,Immer U,Janssen FW

    更新日期:2005-10-01 00:00:00

  • Stenting of malignant upper oesophageal obstruction: experience in a regional hospital in Singapore.

    abstract::Oesophageal stenting for palliation of malignant obstruction with self-expanding metallic stents is undoubtedly well established. Numerous studies have proven it to be safe and easy to perform with good clinical outcomes. However, stenting of the upper oesophagus is still regarded with apprehension, with many endoscop...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e3283496543

    authors: Yim HB

    更新日期:2011-10-01 00:00:00

  • Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.

    abstract:OBJECTIVE:To assess the efficacy and side-effect profile of two currently advocated treatment regimens for eradicating Helicobacter pylori. DESIGN:A randomized, controlled, open, single-centre study. SETTING:A community hospital in The Netherlands. PARTICIPANTS:Seventy-six consecutive patients with (chronic) ulcer d...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00042737-199512000-00011

    authors: de Boer WA,Driessen WM,Jansz AR,Tytgat GN

    更新日期:1995-12-01 00:00:00

  • An interval report on prospective investigation of adjustable silicone gastric banding devices for the treatment of severe obesity.

    abstract::A review and updated report of an ongoing prospective investigation of two different adjustable silicone gastric banding devices is presented. One cohort of this study includes 40 subjects who have had a band placed by laparotomy. A second cohort includes 22 subjects who have had a newly designed adjustable silicone g...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-199902000-00010

    authors: Doherty C,Maher JW,Heitshusen DS

    更新日期:1999-02-01 00:00:00

  • Levofloxacin based regimens for the eradication of Helicobacter pylori.

    abstract:BACKGROUND:A 7 day treatment scheme based on rabeprazole/levofloxacin/amoxycillin or tinidazole achieved an eradication rate over 90%. However, the combination of drugs and duration of treatment for the correct use of levofloxacin in the eradication of are still unclear. OBJECTIVE:To compare the efficacy and tolerabil...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00042737-200212000-00004

    authors: Di Caro S,Zocco MA,Cremonini F,Candelli M,Nista EC,Bartolozzi F,Armuzzi A,Cammarota G,Santarelli L,Gasbarrini A

    更新日期:2002-12-01 00:00:00

  • Primary biliary cirrhosis and idiopathic retroperitoneal fibrosis: a rare association.

    abstract::Primary biliary cirrhosis has rarely been reported to be associated with idiopathic retroperitoneal fibrosis. We describe the case of a 57-year-old man who was confirmed to have both conditions, reflecting the likely autoimmune aetiopathogenesis common to both disorders. ...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200207000-00013

    authors: Tang KH,Schofield JB,Powell-Jackson PR

    更新日期:2002-07-01 00:00:00

  • Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes.

    abstract:OBJECTIVE:There is a controversy about the performance of blood tests for the diagnostic of metabolic liver disease in patients with type-2-diabetes in comparison with patients without type-2-diabetes. These indirect comparisons assumed that the gold-standard is binary, whereas fibrosis stages, steatosis and nonalcohol...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0000000000001606

    authors: Poynard T,Peta V,Deckmyn O,Pais R,Ngo Y,Charlotte F,Ngo A,Munteanu M,Imbert-Bismut F,Monneret D,Housset C,Thabut D,Valla D,Boitard C,Castera L,Ratziu V,FLIP consortium, the FibroFrance Group, the EPIC-3 program and the QU

    更新日期:2020-08-01 00:00:00

  • Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?

    abstract::Effective medical treatment of ulcerative colitis is available. However, 20-40% of patients remain refractory and become steroid dependent, or have chronic activity. Azathioprine and its metabolite 6-mercaptopurine have been found to be effective in this setting, although duration of treatment and doses are not entire...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,评审

    doi:10.1097/00042737-199709000-00004

    authors: Schölmerich J

    更新日期:1997-09-01 00:00:00

  • High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis.

    abstract:OBJECTIVES:Inflammation may be implicated in the haemodynamic deterioration and in the development of complications in patients with cirrhosis. High-sensitivity C-reactive protein (hsCRP) is a marker of low-grade inflammation, and predicts outcomes in patients at risk of ischaemic heart disease. Proinflammatory cytokin...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e328351db6e

    authors: Mortensen C,Andersen O,Krag A,Bendtsen F,Møller S

    更新日期:2012-06-01 00:00:00

  • Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo.

    abstract:OBJECTIVE:To compare zaldaride maleate, a calmodulin inhibitor with gastrointestinal antisecretory properties, with loperamide and a placebo in the treatment of travellers' diarrhoea. DESIGN:Randomized, double-blind, double-dummy study. SETTING:Study clinic staffed by European residents on Nile cruise ships. PATIENT...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Silberschmidt G,Schick MT,Steffen R,Kilpatrick ME,Murphy JR,Oyofo BA,el-Etr S,Gyurech D,Mourad AS,Mathewson JT

    更新日期:1995-09-01 00:00:00

  • Hereditary hyperferritinaemia-cataract syndrome: a challenging diagnosis for the hepatogastroenterologist.

    abstract::Hereditary hyperferritinaemia-cataract syndrome (HHCS) is a relatively rare disorder with an autosomal dominant trait. It can be caused by various mutations within the iron responsive element (IRE) of the L-ferritin gene. These mutations result in an increased translation of L-ferritin mRNA and consequently the accumu...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章,评审

    doi:10.1097/00042737-200511000-00016

    authors: Ferrante M,Geubel AP,Fevery J,Marogy G,Horsmans Y,Nevens F

    更新日期:2005-11-01 00:00:00

  • Cutaneous amyloidosis associated with primary biliary cirrhosis.

    abstract::Primary cutaneous amyloidosis is defined as the deposition of amyloid in the skin in the absence of systemic involvement. The association between primary cutaneous amyloidosis and other diseases, although rare, has been documented for connective tissue disorders such as systemic sclerosis, systemic lupus erythematosus...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/MEG.0b013e32811ec024

    authors: Tafarel JR,Lemos LB,Oliveira PM,Lanzoni VP,Ferraz ML

    更新日期:2007-07-01 00:00:00

  • Contrast-enhanced power Doppler ultrasound in the diagnosis and follow-up of inflammatory abdominal masses in Crohn's disease.

    abstract:OBJECTIVE:The purpose of this study was to evaluate the potential usefulness of contrast-enhanced power Doppler ultrasound in the detection and follow-up of local complications (phlegmon and abscess) in Crohn's disease. METHODS:With this aim, 28 patients with suspected abdominal inflammatory mass were examined with po...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/00042737-200303000-00008

    authors: Esteban JM,Aleixandre A,Hurtado MJ,Maldonado L,Mora FJ,Nogués E

    更新日期:2003-03-01 00:00:00

  • CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.

    abstract:OBJECTIVE:Intestinal metaplasia is a well-established risk factor in the development of stomach cancer. However, since the specificity is low it would be of great practical value to find a marker to separate cases of intestinal metaplasia into low and high risk for progression to dysplasia/carcinoma. So far this has no...

    journal_title:European journal of gastroenterology & hepatology

    pub_type: 杂志文章

    doi:10.1097/01.meg.0000085462.12407.fc

    authors: Gulmann C,Grace A,Leader M,Butler D,Patchett S,Kay E

    更新日期:2003-09-01 00:00:00